Coverage
-
February 23, 2011
A federal judge on Tuesday put a patent infringement suit over inflammatory bowel disorder drug Asacol on hold, following defendant generic-drug maker Roxane Laboratories Inc.'s agreement to delay the launch of a generic version of the drug until September.
3 other articles on this case.
View all »